It’s not every day a startup from Chubbuck, Idaho, yes, Chubbuck, drops a clinical intelligence platform that’s not just AI-powered but AI-native, trained to speak nephrology like a seasoned practitioner. That’s Nephrolytics, with sharp tech doing heavy clinical lifting in a field most of the Valley wouldn’t touch without gloves and a translator. This week, they locked in a $2.5M SAFE round, backed by a syndicate of physician investors and strategic healthcare leaders who don’t just write checks, they write the future of precision medicine.
Let’s rewind the tape. Nephrolytics wasn’t born in a pitch deck. It was born in the ICU, the dialysis center, the exam room. Founded by Tina Gill, MBA (Co-Founder & CEO), Fahim Rahim, MD, MBA (Co-Founder & President), Naeem Rahim, MD, FASN (Co-Founder & CMO), and Ali Nadeem (Co-Founder & COO), this crew didn’t see a market gap, they lived it. The data was fragmented, workflows were broken, and decision-making looked more like a coin flip than a clinical strategy. So they built Saya™ and Lumi™, two AI agents that don’t just assist, they co-pilot the entire care experience.
Saya™ automates SOAP notes, builds patient smart summaries, and delivers real-time decision support across EMRs, labs, hospital systems, and health exchanges. Lumi™ comes in with predictive financial insights, revenue forecasting, and real-time operational benchmarks, all tailored for nephrology, not patchwork from a generalist EHR module. It’s not a retrofit. It’s a rebuild.
Deployed at the Idaho Kidney Institute and showcased at the 2025 Renal Physicians Association Annual Meeting, Nephrolytics is already managing 325 ESRD patients and tracking 500 more in early-stage care. Outcomes? Try a 40% cut in charting time, 33% jump in coding accuracy, and nearly 20% lift in revenue per provider. That’s not traction, that’s evidence.
And here’s the move that too many founders miss: Nephrolytics didn’t spend the last 12 months on hype. They spent it on delivery. That’s why this round didn’t need a celebrity lead or 12-slide seed saga. The work spoke, and the right people listened. Now with offices in Idaho and Boulder, they’re scaling onboarding, building out the product, and gunning for national reach across nephrology practices and large dialysis organizations.
You want a business case? Here it is. Build for the workflow, not the wow. Solve the boring problems better than anyone else, and the industry will meet you with capital and contracts. Nephrolytics didn’t just raise, they earned. That’s precision medicine with precision execution.
